Gene Therapy & Molecular Biology Volume 2 Issue A

c i e n c e 2 3 5 , 1 7 7 1 8 2 .

Slamon D, Godolphin W, Jones L, Holt J, Wong S, Keith D, Levine W, Stuart S, Udove J, Ullrich A, and Press M. (1989) Studies of the HER-2/neu protoncogene in human breast and ovarian carcinomas. Science 244, 707-712.

Smith, G.L., Mackett, M. and Moss, B. (1983) Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature 302, 490-495.

Spiess PJ, Yang JC, Rosenberg SA. (1987) in vivo antitumor activity of tumor-inďƒžltrating lymphocytes expanded in recombinant interleukin-2. J Natl Cancer Inst 79, 1067-1075.

Taylor J, Tartaglia J, Riviere M, Duret C, Languet B, Chappuis G, and Paoletti E. (1994) Applications of canarypox (ALVAC) vectors in human and veterinary vaccination. Dev. Biol. Stand 82, 131-135.

Taylor J, Trimarchi C, Weinberg R, Languet B, Guillemin F, Desmettre P, and Paoletti E. (1991) Efďƒžcacy studies on a canarypox-rabies recombinant virus. Vaccine 9, 190-193.

Toes RE, Blom RJ, Offringa R, Kast WM, Melief C J. (1996) Enhanced tumor outgrowth after peptide vaccination.

J Immunol 156, 3911-3918.

T o p a l i a n S L , R i v o l t i n i L , M a n c i n